linagliptin vs rifampin

According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.

Side-by-side comparison of linagliptin and rifampin. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

minor Known Drug Interaction

Inducers of P-glycoprotein or CYP3A4 Enzymes Clinical Impact Rifampin decreased linagliptin exposure, suggesting that the efficacy of linagliptin may be reduced when administered in combination with a strong P-gp or CYP3A4 inducer. ( 7 ) Strong P-glycoprotein/CYP3A4 Inducer: Efficacy may be reduced when administered in combination (e.g., rifampin).

Drug Class
linagliptin DPP-4 Inhibitor
rifampin Rifamycin Antibiotic
Type
linagliptin Prescription
rifampin Prescription
Summary
linagliptin

No summary available.

rifampin

Rifampin is an antibiotic medicine. It fights bacteria in your body to treat infections.

What It Treats
linagliptin

Information not available.

rifampin

Rifampin treats tuberculosis (TB) and helps eliminate the bacteria that cause meningitis from your nose and throat. It is important to use rifampin only for infections that are proven or strongly suspected to be caused by bacteria. This helps to prevent bacteria from becoming resistant to the medicine.

How It Works
linagliptin

Information not available.

rifampin

Rifampin works by stopping bacteria from growing and multiplying. It does this by blocking a key enzyme that the bacteria need to make proteins. This helps your body fight off the infection.

Common Side Effects
linagliptin
  • Runny nose or sore throat
  • Diarrhea
rifampin
  • Heartburn
  • Upset stomach
  • Loss of appetite
  • Nausea
  • Vomiting
FAERS Reports
linagliptin
  • Blood Glucose Increased 1,326
  • Diarrhoea 1,196
  • Nausea 1,138
  • Fatigue 1,028
  • Dyspnoea 998
rifampin
  • Drug Interaction 970
  • Drug Reaction With Eosinophilia And Systemic Symptoms 727
  • Nausea 628
  • Condition Aggravated 550
  • Pyrexia 541
Serious Warnings
linagliptin

No specific warnings noted.

rifampin

Rifampin can cause liver problems. Tell your doctor right away if you have yellowing of the skin or eyes, dark urine, or stomach pain. Rifampin can also cause blood problems. Tell your doctor if you have unusual bleeding or bruising.

Pregnancy
linagliptin

No pregnancy information available.

rifampin

Tell your doctor if you are pregnant or plan to become pregnant. Rifampin can make birth control pills less effective, so use other forms of birth control. Talk to your doctor if you are breastfeeding.

Also Compare, Nearby Drugs

How to Read This linagliptin vs rifampin Comparison

linagliptin is classified in the DPP-4 Inhibitor drug class, while rifampin sits within the Rifamycin Antibiotic class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, linagliptin has 5,686 submissions while rifampin has 3,416. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to rifampin speeds up how fast your body breaks down linagliptin, which lowers the amount of medicine in your system. this can make the diabetes drug less effective at controlling your blood sugar.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for linagliptin or rifampin.

Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.